Table of ContentsView AllTable of ContentsHow It WorksUsesBefore TakingWarnings and PrecautionsContraindicationsInteractionsSide EffectsDosageMisuseDiscontinuation
Table of ContentsView All
View All
Table of Contents
How It Works
Uses
Before Taking
Warnings and Precautions
Contraindications
Interactions
Side Effects
Dosage
Misuse
Discontinuation
Close
If you’ve been given a prescription for Cymbalta or want to learn more about whether it is right for you, it’s helpful to understand how this antidepressant works. We also discuss how to take Cymbalta safely, which involves knowing its precautions and contraindications, as well as its potential side effects.
The Most Important Things to Know About Cymbalta (Duloxetine Hydrochloride)
How Cymbalta Works
As an SNRI, duloxetine inhibits the reuptake of the neurotransmittersserotonin and norepinephrinein the central nervous system. As a result, this increases the amounts available in the brain.
These brain chemicals help regulate mood. So, increasing their levels can relieve symptoms of depression and anxiety. A 2020 review of 85 studies determined that duloxetine is effective for these purposes, both as a short- and long-term treatment.
Improvements in sleep, energy levels, and appetite may be noticed within the first one or two weeks of starting this drug; while other depression and anxiety symptoms may take up to eight weeks to improve.
Uses for Cymbalta
The U.S. Food and Drug Administration has approved Cymbalta for use in the treatment of two mental health conditions:major depressive disorder(MDD) andgeneralized anxiety disorder(GAD). It is also approved to help treat fibromyalgia, diabetic peripheral neuropathy, and chronic musculoskeletal pain.
Off-Label Cymbalta UsesCymbalta is sometimes prescribed off-label in the treatment of stress urinary incontinence.Off-label use means that there is a lack of evidence supporting the safety and/or effectiveness of the drug for that specific condition.
Off-Label Cymbalta Uses
Cymbalta is sometimes prescribed off-label in the treatment of stress urinary incontinence.Off-label use means that there is a lack of evidence supporting the safety and/or effectiveness of the drug for that specific condition.
Before Taking Cymbalta
Before prescribing duloxetine, your healthcare provider will evaluate your symptoms and health history. This can help determine if you have any other health conditions that may preclude the use of this medication, or if you are taking any other medications or supplements that may influence the drug’s actions.
This is also a good time to become familiar with the warnings, contraindications, and interactions of this drug so you know how to use it safely. Learning its potential side effects is important too, one of which is an increased risk ofsuicidal thoughts or behaviorsin children, teens, and young adults.
Because duloxetine may increase suicide risk in some individuals, talk to your provider about monitoring your symptoms upon beginning this drug.
Warnings and Precautions for Cymbalta
All antidepressants, including Cymbalta, are required to carry a black box warning.This warning states that antidepressants may increase the risk of suicidality in children and young adults under the age of 25.
People taking Cymbalta should be observed closely for worsening depression and suicidality, especially at the beginning of treatment and when changes are made to their prescribed dose. Symptoms to watch for include anxiety, agitation, restlessness, panic attacks, insomnia, irritability, hostility, impulsivity, andhypomania or mania.
If you are having suicidal thoughts, contact theNational Suicide Prevention Lifelineat988for support and assistance from a trained counselor. If you or a loved one are in immediate danger, call 911.For more mental health resources, see ourNational Helpline Database.
If you are having suicidal thoughts, contact theNational Suicide Prevention Lifelineat988for support and assistance from a trained counselor. If you or a loved one are in immediate danger, call 911.
For more mental health resources, see ourNational Helpline Database.
Additional warnings for Cymbalta include a potential risk of:
Serotonin Syndrome
Caution should be used when taking Cymbalta with othermedications that increase serotonin, which includes other antidepressants. When taken with drugs that also affect serotonin levels, there is a risk of a serious complication known as serotonin syndrome.
Symptoms ofserotonin syndromecan develop in minutes or hours and include increased blood pressure, elevated heart rate, sweating, loss of coordination, agitation, and confusion.You might also experience hallucinations, have overactive reflexes, or have abnormal eye movements.
If you or a loved one develop any of these symptoms, contact your healthcare provider immediately or go to the emergency room as this condition can be life-threatening.
Contraindications for Cymbalta
Additionally, it is unclear as to whether it is safe to use Cymbalta when pregnant, with some studies finding that duloxetine may be associated with an increased risk of cardiac malformation in the fetus and postpartum hemorrhage.Therefore, it is recommended that the benefits be weighed against the risks before taking Cymbalta during pregnancy.
Drug Interactions for Cymbalta
Duloxetine can interact with a number of other medications and supplements. An interaction can impact the way that this antidepressant works or it may influence the effects of these other substances.
Drugs known to interact with duloxetine include:
To minimize the risk of potentially dangerous interactions, always tell your healthcare provider about any other prescription medications, over-the-counter drugs, vitamins, herbs, or other supplements that you are taking.
Is Mixing Cymbalta (Duloxetine) and Alcohol Safe?
Potential Side Effects of Cymbalta
Although duloxetine is considered a safe drug and is generally well-tolerated,side effects can occur.
Common Side Effects
Typically, these side effects go away within the first weeks of treatment,after your body adjusts to the drug. If they don’t or if the effects become bothersome, talk with your healthcare provider. They may adjust the dosage or switch you to a new medication.
When first starting duloxetine, you might also feel faint, lightheaded, or dizzy when moving too quickly from a lying to a standing position.This is due to blood pressure changes. Getting up slowly can help ease this effect.
Severe Side Effects
More serious side effects of duloxetine can include:
If serious side effects occur after taking Cymbalta, contact your healthcare provider or go to the nearest emergency room for immediate treatment.
Dosage of Cymbalta
When prescribed for depression or anxiety, Cymbalta is often administered to a target dose of 60 milligrams (mg) per day.The maximum dosage for this drug is 120 mg daily. However, higher doses of duloxetine are associated with more adverse effects without more positively impacting symptom reduction.
These dosages are according to the drug manufacturer. Check your prescription and talk to your healthcare provider to ensure that you are taking the right dose for you.
How to Take
The delayed-release capsules should be swallowed whole and never crushed or chewed. It is not necessary to take this medication with food.
If you miss a dose of duloxetine, you should take it as soon as you remember, unless it is close to the time for your next dose. In this case, simply skip the missed dose and take your regular dose on schedule.
Never take two doses at once to make up for a missed dose as it is possible tooverdose on this drug. Symptoms of a Cymbalta overdose can include rapid heart rate, seizures, and high blood pressure; when taken in high doses with other drugs, it can lead to low blood pressure and coma.
Contact emergency services immediately if you believe that you or someone else has overdosed on Cymbalta.
Cymbalta Misuse
Misusing drugscan lead to greater side effects and the potential for overdose. That’s why it’s important to use Cymbalta as directed. Speak with your healthcare provider if you are concerned that you may be developing an addiction or tolerance to this drug.
If you or a loved one are struggling with substance use or addiction, contact theSubstance Abuse and Mental Health Services Administration (SAMHSA) National Helplineat1-800-662-4357for information on support and treatment facilities in your area.For more mental health resources, see ourNational Helpline Database.
If you or a loved one are struggling with substance use or addiction, contact theSubstance Abuse and Mental Health Services Administration (SAMHSA) National Helplineat1-800-662-4357for information on support and treatment facilities in your area.
Discontinuing Cymbalta
It is common to experiencewithdrawal symptomsafter reducing the dosage of or completely stopping antidepressant drugs such as duloxetine. Some of the most reportedCymbalta withdrawal symptomsinclude:
Your physician can advise you about how to reduce or stop your medication, which may involvegradually reducing your dosage. The latter gives your body time to adjust to lower amounts of the drug before eliminating it altogether.
Never stop taking Cymbalta, or any other antidepressant, without first discussing this with your healthcare provider.
How Long Does Withdrawal From Antidepressants Last?
13 SourcesVerywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltanás T.A systematic review of efficacy, safety, and tolerability of duloxetine.Front Psychiatry. 2020;11:554899. doi:10.3389/fpsyt.2020.554899National Alliance on Mental Illness.Duloxetine (Cymbalta).U.S. Food and Drug Administration.Cymbalta (duloxetine hydrochloride) delayed-release capsules for oral use label.Dairo O, Akram I, Bratcher C, Hailemeskel B.Review of duloxetine use in the management of stress urinary incontinence and students' survey.Arch Pharm Pract. 2023;14(2):54-58. doi:10.51847/j8eXNDm7SdSpielmans GI, Spence-Sing T, Parry P.Duty to warn: Antidepressant black box suicidality warning is empirically justified.Front Psychiatry. 2020;11:18. doi:10.3389/fpsyt.2020.00018Wang RZ, Vashistha V, Kaur S, Houchens N.Serotonin syndrome: Preventing, recognizing, and treating it.Cleve Clin J Med. 2016;83(11):810-817. doi:10.3949/ccjm.83a.15129National Library of Medicine, MedlinePlus.Serotonin syndrome.National Library of Medicine, MedlinePlus.Duloxetine.Huybrechts K, Bateman BT, Pawar A, et al.Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.BMJ. 2020;368:m237. coi:10.1136/bmj.m237Muscatello M, Zoccali R, Pandolfo G, et al.Duloxetine in psychiatric disorders: Expansions beyond major depression and generalized anxiety disorder.Front Psychiatry. 2019;10:772. doi:10.3389/fpsyt.2019.00772Isbister GK, Polanski R, Cooper JM, Keegan M, Isoardi KZ.Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications.Clin Toxic. 2022;60(9):1019-1023. doi:10.1080/15563650.2022.2083631Gao W, Chen R, Xie N, Tang D, Zhou B, Wang D.Duloxetine-induced neural cell death and promoted neurite outgrowth in N2a cells.Neurotoxic Res. 2020;38:859-870. doi:10.1007/s12640-020-00216-xFava GA, Banasi G, Lucente M, Offidani E, Cosci F, Guidi J.Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review.Psychother Psychosom. 2018;87(4):195-203. doi:10.1159/000491524
13 Sources
Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltanás T.A systematic review of efficacy, safety, and tolerability of duloxetine.Front Psychiatry. 2020;11:554899. doi:10.3389/fpsyt.2020.554899National Alliance on Mental Illness.Duloxetine (Cymbalta).U.S. Food and Drug Administration.Cymbalta (duloxetine hydrochloride) delayed-release capsules for oral use label.Dairo O, Akram I, Bratcher C, Hailemeskel B.Review of duloxetine use in the management of stress urinary incontinence and students' survey.Arch Pharm Pract. 2023;14(2):54-58. doi:10.51847/j8eXNDm7SdSpielmans GI, Spence-Sing T, Parry P.Duty to warn: Antidepressant black box suicidality warning is empirically justified.Front Psychiatry. 2020;11:18. doi:10.3389/fpsyt.2020.00018Wang RZ, Vashistha V, Kaur S, Houchens N.Serotonin syndrome: Preventing, recognizing, and treating it.Cleve Clin J Med. 2016;83(11):810-817. doi:10.3949/ccjm.83a.15129National Library of Medicine, MedlinePlus.Serotonin syndrome.National Library of Medicine, MedlinePlus.Duloxetine.Huybrechts K, Bateman BT, Pawar A, et al.Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.BMJ. 2020;368:m237. coi:10.1136/bmj.m237Muscatello M, Zoccali R, Pandolfo G, et al.Duloxetine in psychiatric disorders: Expansions beyond major depression and generalized anxiety disorder.Front Psychiatry. 2019;10:772. doi:10.3389/fpsyt.2019.00772Isbister GK, Polanski R, Cooper JM, Keegan M, Isoardi KZ.Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications.Clin Toxic. 2022;60(9):1019-1023. doi:10.1080/15563650.2022.2083631Gao W, Chen R, Xie N, Tang D, Zhou B, Wang D.Duloxetine-induced neural cell death and promoted neurite outgrowth in N2a cells.Neurotoxic Res. 2020;38:859-870. doi:10.1007/s12640-020-00216-xFava GA, Banasi G, Lucente M, Offidani E, Cosci F, Guidi J.Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review.Psychother Psychosom. 2018;87(4):195-203. doi:10.1159/000491524
Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltanás T.A systematic review of efficacy, safety, and tolerability of duloxetine.Front Psychiatry. 2020;11:554899. doi:10.3389/fpsyt.2020.554899National Alliance on Mental Illness.Duloxetine (Cymbalta).U.S. Food and Drug Administration.Cymbalta (duloxetine hydrochloride) delayed-release capsules for oral use label.Dairo O, Akram I, Bratcher C, Hailemeskel B.Review of duloxetine use in the management of stress urinary incontinence and students' survey.Arch Pharm Pract. 2023;14(2):54-58. doi:10.51847/j8eXNDm7SdSpielmans GI, Spence-Sing T, Parry P.Duty to warn: Antidepressant black box suicidality warning is empirically justified.Front Psychiatry. 2020;11:18. doi:10.3389/fpsyt.2020.00018Wang RZ, Vashistha V, Kaur S, Houchens N.Serotonin syndrome: Preventing, recognizing, and treating it.Cleve Clin J Med. 2016;83(11):810-817. doi:10.3949/ccjm.83a.15129National Library of Medicine, MedlinePlus.Serotonin syndrome.National Library of Medicine, MedlinePlus.Duloxetine.Huybrechts K, Bateman BT, Pawar A, et al.Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.BMJ. 2020;368:m237. coi:10.1136/bmj.m237Muscatello M, Zoccali R, Pandolfo G, et al.Duloxetine in psychiatric disorders: Expansions beyond major depression and generalized anxiety disorder.Front Psychiatry. 2019;10:772. doi:10.3389/fpsyt.2019.00772Isbister GK, Polanski R, Cooper JM, Keegan M, Isoardi KZ.Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications.Clin Toxic. 2022;60(9):1019-1023. doi:10.1080/15563650.2022.2083631Gao W, Chen R, Xie N, Tang D, Zhou B, Wang D.Duloxetine-induced neural cell death and promoted neurite outgrowth in N2a cells.Neurotoxic Res. 2020;38:859-870. doi:10.1007/s12640-020-00216-xFava GA, Banasi G, Lucente M, Offidani E, Cosci F, Guidi J.Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review.Psychother Psychosom. 2018;87(4):195-203. doi:10.1159/000491524
Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltanás T.A systematic review of efficacy, safety, and tolerability of duloxetine.Front Psychiatry. 2020;11:554899. doi:10.3389/fpsyt.2020.554899
National Alliance on Mental Illness.Duloxetine (Cymbalta).
U.S. Food and Drug Administration.Cymbalta (duloxetine hydrochloride) delayed-release capsules for oral use label.
Dairo O, Akram I, Bratcher C, Hailemeskel B.Review of duloxetine use in the management of stress urinary incontinence and students' survey.Arch Pharm Pract. 2023;14(2):54-58. doi:10.51847/j8eXNDm7Sd
Spielmans GI, Spence-Sing T, Parry P.Duty to warn: Antidepressant black box suicidality warning is empirically justified.Front Psychiatry. 2020;11:18. doi:10.3389/fpsyt.2020.00018
Wang RZ, Vashistha V, Kaur S, Houchens N.Serotonin syndrome: Preventing, recognizing, and treating it.Cleve Clin J Med. 2016;83(11):810-817. doi:10.3949/ccjm.83a.15129
National Library of Medicine, MedlinePlus.Serotonin syndrome.
National Library of Medicine, MedlinePlus.Duloxetine.
Huybrechts K, Bateman BT, Pawar A, et al.Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.BMJ. 2020;368:m237. coi:10.1136/bmj.m237
Muscatello M, Zoccali R, Pandolfo G, et al.Duloxetine in psychiatric disorders: Expansions beyond major depression and generalized anxiety disorder.Front Psychiatry. 2019;10:772. doi:10.3389/fpsyt.2019.00772
Isbister GK, Polanski R, Cooper JM, Keegan M, Isoardi KZ.Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications.Clin Toxic. 2022;60(9):1019-1023. doi:10.1080/15563650.2022.2083631
Gao W, Chen R, Xie N, Tang D, Zhou B, Wang D.Duloxetine-induced neural cell death and promoted neurite outgrowth in N2a cells.Neurotoxic Res. 2020;38:859-870. doi:10.1007/s12640-020-00216-x
Fava GA, Banasi G, Lucente M, Offidani E, Cosci F, Guidi J.Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review.Psychother Psychosom. 2018;87(4):195-203. doi:10.1159/000491524
Meet Our Review Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?HelpfulReport an ErrorOtherSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?HelpfulReport an ErrorOtherSubmit
What is your feedback?